This document is a publication of a patent application filed by Assembly Biosciences, Inc. for a novel crystalline form of pritelivir. The application details pharmaceutical compositions, methods for production, and the use of this crystalline form in treating herpes virus infections. The filing date was August 28, 2023, and the publication number is US20260085068A1.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on drug manufacturers. However, it signifies potential future intellectual property protection and market exclusivity for Assembly Biosciences, Inc. regarding this specific crystalline form of pritelivir. Companies involved in antiviral drug development or herpes treatment should monitor the progress of this patent application and any granted patents.